SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-16-532735
Filing Date
2016-04-07
Accepted
2016-04-07 06:06:06
Documents
3

Document Format Files

Seq Description Document Type Size
1 POS AM d173786dposam.htm POS AM 53248
2 EX-5.1 d173786dex51.htm EX-5.1 14007
3 GRAPHIC g90362401.jpg GRAPHIC 11474
  Complete submission text file 0001193125-16-532735.txt   84136
Mailing Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746
Business Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-205001 | Film No.: 161558720
SIC: 2834 Pharmaceutical Preparations